Medicine and Dentistry
Uterine Cancer
100%
Ovarian Cancer
70%
Endometrium Carcinoma
50%
Cervical Cancer
46%
Krukenberg Tumor
40%
Neoplasm
39%
Diseases
36%
Recurrent Disease
31%
Radiation Therapy
28%
Gene Mutation
27%
Pelvis
27%
Pleura Effusion
23%
Pericardial Fluid
23%
CA-125
23%
Endometriosis
23%
Cancer
23%
Thymus Cancer
23%
Mycobacterium Tuberculosis
23%
Ascites
23%
Genetic Analysis
23%
Convergent Evolution
23%
Antibiotic Resistance
23%
Cell Wall
23%
Cisplatin
23%
DNA Repair
23%
Rifampicin
23%
Gynecological Oncology
23%
Morcellation
23%
Health Care Cost
23%
In Vitro
23%
Fluorouracil
23%
Biological Marker
23%
Homologous Recombination
23%
Poly ADP Ribose Polymerase
23%
Cediranib
23%
Venous Thromboembolism
23%
Intraperitoneal Chemotherapy
23%
Olaparib
23%
Sentinel Lymph Node
23%
Malignant Neoplasm
17%
Adenocarcinoma
15%
Disease Course
14%
PARP Inhibitor
13%
Overall Survival
11%
Hysterectomy
11%
Ethamoxytriphetol
11%
Carcinoma Cell
11%
Non-Homologous End Joining
11%
Protein Complex
11%
Single Drug Dose
11%
Keyphrases
Special AT-rich Sequence-binding Protein 1
46%
5-fluorouracil (5-FU)
38%
Tumor
33%
T Cells
32%
Cervical Cancer
31%
Programmed Death-ligand 1 (PD-L1)
26%
In Cancer
26%
Transforming Growth Factor-β
26%
Tumor-promoting
23%
Overexpression
23%
Autoreactive T Cells
23%
Cancer-related
23%
SATB1
23%
Positive Selection
23%
Drug-resistant Mycobacterium Tuberculosis
23%
Genomic Analysis
23%
Epigenetic Repression
23%
Dendritic Cells
23%
Combined Modality Therapy
23%
Malignant Thymoma
23%
High Risk
23%
Society of Gynecologic Oncology
23%
Concurrent Cisplatin
23%
Chemoradiation
23%
Retrospective Review
23%
FOXP1
23%
Chemotherapy
23%
Risk Subset
23%
Locally Advanced Cervical Cancer
23%
Radical Radiotherapy
23%
Gene Expression
23%
Antitumor T Cells
23%
Cervical Cancer Patients
23%
Connective Tissue
23%
Molecular Characterization
23%
Early-stage Cervical Cancer
23%
Ovarian Cancer
23%
Integrated Genomics
23%
Transcription Factor
23%
Therapy-induced Senescence
23%
Stage IV Endometriosis
23%
Genomic Characterization
23%
CLIC4
23%
Preoperative Prophylaxis
23%
Robotic Staging
23%
Cisplatin
19%
Mycobacterium Tuberculosis (M. tb)
15%
Resistant Isolate
15%
Treatment-related Morbidity
15%
Radical Hysterectomy
15%
Biochemistry, Genetics and Molecular Biology
Binding Protein
46%
AT Rich Sequence
46%
Synapsin I
46%
T Cell
46%
Genomics
46%
ARID1A
35%
Cancer Growth Factor
26%
Epigenetic Repression
23%
Programmed Cell Death 1
23%
SATB1
23%
Mycobacterium Tuberculosis
23%
Dendritic Cell
23%
Keratin
23%
Wart Virus
23%
Telomere
23%
Nicotinamide Phosphoribosyltransferase
23%
Genome Instability
23%
CA-125
23%
Diagnostic Biomarker
23%
Transcription Factors
23%
CARM1
23%
Homologous Recombination
23%
EZH2
23%
Poly ADP Ribose Polymerase
23%
Anabolism
15%
Cisplatin
13%
Convergent Evolution
11%
DNA Repair
11%
Gene Mutation
11%
Genetics
11%
Antibiotic Resistance
11%
Blood Plasma
11%
PD-L1
11%
Gene Expression
11%
Human Papillomavirus Type 18
11%
Mutagenesis
11%
Mutated Genes
11%
Human Papillomavirus Type 16
11%
Long Non-Coding RNA
11%
CD8
11%
Lapatinib
11%
ERBB3
11%
HLA-A
11%
KRAS
11%
APOBEC
11%
Lymphocyte
8%
Secretion (Process)
8%
Promoter Region
8%
Tumor Progression
7%
Protein Complexes
7%
